# Icariin (Flavonol Glycoside)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/icariin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 6 / 10
**Category:** Compound
**Also Known As:** C₃₃H₄₀O₁₅, Icariside, Horny Goat Weed extract, Yin Yang Huo active compound, Epimedium flavonoid, Prenylated flavonol glycoside, Barrenwort extract

## Overview

Icariin is a prenylated flavonol glycoside isolated from Epimedium species that promotes bone formation through cAMP/PKA/CREB signaling activation. This bioactive compound enhances osteoblast activity and reverses bone loss by modulating osteoprotegerin pathways.

## Health Benefits

• Promotes bone formation and mineralization through activation of cAMP/PKA/CREB signaling in osteoblasts (demonstrated in rat models and cell studies)
• Enhances peak bone mass development via primary cilia-localized signaling pathways (shown in young rat studies)
• Reverses osteoprotegerin-deficient bone phenotypes through Wnt/β-catenin-BMP signaling (demonstrated in mouse models)
• Increases nitric oxide levels and vasodilation through PDE5/PDE4 inhibition (mechanism identified in preclinical research)
• Shows more potent osteogenic effects than genistein despite weaker estrogenic activity (comparative cell culture studies)

## Mechanism of Action

Icariin activates the cAMP/PKA/CREB signaling cascade in osteoblasts, promoting bone matrix synthesis and mineralization. The compound enhances peak bone mass development through primary cilia-localized signaling pathways and modulates the osteoprotegerin/RANKL system. Additionally, icariin demonstrates PDE5 inhibitory activity and influences estrogen receptor pathways.

## Clinical Summary

Current evidence for icariin is primarily derived from rat models and in vitro cell studies rather than human clinical trials. Rat studies show enhanced bone formation and reversal of osteoprotegerin-deficient bone loss, with young rat models demonstrating improved peak bone mass development. Cell culture studies confirm osteoblast activation and increased bone matrix protein expression. However, human clinical data remains limited, making it difficult to establish definitive therapeutic efficacy and optimal dosing protocols.

## Nutritional Profile

{"macronutrients": {"protein": "Not applicable", "fiber": "Not applicable"}, "micronutrients": {"vitamins": "Not applicable", "minerals": "Not applicable"}, "bioactive_compounds": {"icariin": "Concentration varies depending on the source, typically found in concentrations ranging from 0.1% to 5% in Epimedium species extracts"}, "bioavailability_notes": "Icariin's bioavailability is generally low due to poor water solubility and rapid [metabolism](/ingredients/condition/weight-management), but it can be improved through formulation strategies such as nanoparticles or phospholipid complexes."}

## Dosage & Preparation

No clinically studied dosage ranges for humans have been established, as human trials are absent from the current research literature. Preclinical studies used icariin in animal models without specifying standardized doses for human use. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Icariin is generally well-tolerated in animal studies, but human safety data is limited. Due to its PDE5 inhibitory activity, icariin may potentially interact with nitrates and [blood pressure](/ingredients/condition/heart-health) medications. The compound may also influence hormonal pathways, raising concerns for individuals with hormone-sensitive conditions. Pregnancy and breastfeeding safety has not been established, and consultation with healthcare providers is recommended before supplementation.

## Scientific Research

Current research on icariin is limited to preclinical animal models and in vitro studies, with no human clinical trials, RCTs, or meta-analyses reported in the available literature. Studies include rat models examining bone mass development and mouse models investigating bone formation pathways, but no PubMed PMIDs for human trials were identified.

## Historical & Cultural Context

Icariin is isolated from Epimedium, a traditional Chinese medicine (TCM) herb historically used for treating bone fractures and preventing [osteoporosis](/ingredients/condition/bone-health). The herb has been used in traditional Chinese medicine for an extended historical period, though specific duration details are not provided.

## Synergistic Combinations

Calcium, Vitamin D3, Magnesium, Vitamin K2, Collagen

## Frequently Asked Questions

### What is the typical icariin dosage for bone health?

Human dosage guidelines are not well-established due to limited clinical trials. Animal studies used doses equivalent to 10-50mg per day in humans, but optimal therapeutic doses require further clinical research.

### How long does icariin take to show bone health effects?

Rat studies showed measurable bone formation improvements within 4-8 weeks of treatment. However, human bone remodeling typically takes 3-6 months, so effects may require longer-term supplementation.

### Can icariin be taken with calcium and vitamin D supplements?

No known contraindications exist between icariin and bone health supplements like calcium or vitamin D. The mechanisms are complementary, as icariin enhances osteoblast signaling while calcium provides building material for bone matrix.

### Is icariin safe for postmenopausal women with osteoporosis?

While animal studies suggest bone-protective effects, human safety data is insufficient for postmenopausal women. Potential hormonal interactions require medical supervision, especially for those on hormone replacement therapy or osteoporosis medications.

### What's the difference between icariin and horny goat weed extract?

Icariin is the specific bioactive flavonoid compound, while horny goat weed (Epimedium) extract contains multiple compounds including varying icariin concentrations. Standardized icariin supplements provide more consistent dosing than whole plant extracts.

### Does icariin absorption improve when taken with food or fat?

Icariin is a flavonol glycoside with moderate lipophilicity, suggesting that absorption may be enhanced when consumed with dietary fat, though human bioavailability studies remain limited. Most preclinical research has not specifically evaluated food-fat interactions with icariin supplementation. Taking icariin with meals is generally recommended to support gastrointestinal tolerance and potentially optimize absorption, similar to other flavonoid compounds.

### Does icariin interact with osteoporosis medications like bisphosphonates?

No significant drug interactions between icariin and bisphosphonates have been documented in clinical literature, as they work through distinct mechanisms (icariin activates osteoblast signaling while bisphosphonates inhibit osteoclast activity). However, because both target bone metabolism, combining them should be discussed with a healthcare provider to ensure complementary rather than redundant therapeutic effects. Separating administration timing may be prudent, though specific guidance is not yet established.

### What does the clinical evidence show about icariin's effectiveness compared to standard osteoporosis treatments?

Most evidence for icariin comes from preclinical studies in animal models and cell cultures showing promise in bone formation and Wnt/β-catenin signaling activation, but human clinical trials remain sparse and small-scale. Available human studies suggest modest benefits for bone mineral density and bone turnover markers, though they lack the robust long-term safety and efficacy data available for FDA-approved osteoporosis drugs. Icariin may be better considered as a complementary approach rather than a replacement for established pharmacological treatments in moderate-to-severe osteoporosis.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*